Initiator Pharma: Indication expansion - Redeye
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Aktieanalys

Initiator Pharma: Indication expansion - Redeye

{newsItem.title}

Redeye briefly comments on the announcement of an indication expansion made by Initiator Pharma earlier today. We are encouraged to learn that the company will expand its two clinical assets, pudafensine and IP2018, to a broader sexual health franchise including both male Erectile Dysfunction (ED) and Female Sexual Dysfunction (FSD) indications.

Länk till analysen i sin helhet: https://www.redeye.se/research/969499/initiator-pharma-indication-expansion?utm_source=finwire&utm_medium=RSS

Nyheter om Initiator Pharma

Läses av andra just nu

Om aktien Initiator Pharma

Senaste nytt